Short answer: sexual wellness cost is a stack — evaluation, follow-up or membership, medication, pharmacy/shipping, and insurance — not one sticker price. This article explains that structure; live hub numbers are the place for current figures.
There's no single price for sexual wellness treatment — the real total combines the evaluation, follow-up or membership fees, any targeted screening, the medication itself, and pharmacy or shipping costs. Rather than print numbers that go stale fast, here's what actually drives the cost.
The First Question: What's Actually Being Offered
The most important thing to establish upfront is what treatment you're actually being offered. An FDA-approved product, that same product used off-label, and a pharmacy-compounded formulation all carry different regulatory status, different evidence behind them, different delivery methods, and potentially different insurance or billing handling entirely.
Evaluation Scope Affects Consultation Cost
A legitimate low-libido consultation should assess whether you have a specific condition like acquired, generalized HSDD, or whether low desire is better explained by pain with sex, menopause symptoms, medication effects, mood, relationship factors, sleep disruption, chronic illness, or substance use.[3]A short intake questionnaire can be part of that, but shouldn't be the entire diagnostic process — the International Society for the Study of Women's Sexual Health recommends a real sexual and medical history, with the Decreased Sexual Desire Screener as a useful supporting tool, not a replacement.[3] The scope of that evaluation is itself one driver of consultation cost — a genuinely thorough intake takes more clinician time than a five-question form.
Billing Structure Varies by Provider
Providers charge in different ways: a one-time consultation, separate follow-up visits, a monthly or annual membership, or some hybrid. Before enrolling anywhere, confirm whether the advertised fee includes clinician visits, ongoing messaging, prescription renewals, the medication itself, pharmacy dispensing, shipping, and cancellation or pause options.
FDA-Approved Vyleesi Has Its Own Cost Shape
FDA-approved bremelanotide is sold as Vyleesi — an on-demand subcutaneous autoinjector, approved for acquired, generalized HSDD in premenopausal women, delivering 1.75 mg/0.3 mL per dose, injected into the abdomen or thigh at least 45 minutes before anticipated activity.[5]A Vyleesi-based care pathway has costs tied to the branded medication itself, how many doses or refills are prescribed, the prescribing visit, follow-up, and how your specific insurance or pharmacy benefit handles it. It's not a fair comparison to weigh this directly against a daily oral medication, a nasal spray, or a compounded multi-dose preparation — the use patterns are genuinely different.
Compounded Bremelanotide Changes the Cost Structure
Some providers offer compounded bremelanotide, often marketed as PT-141. This is prepared by a pharmacy under a prescription and isn't FDA-approved as a finished drug product, even though it contains the same active ingredient as Vyleesi.[1]It can differ from Vyleesi in concentration, formulation, injection device, and instructions — differences that genuinely affect price structure, but also mean it shouldn't be described as automatically identical or "brand-equivalent" to the FDA-approved product.[1] Compounded drugs aren't reviewed by the FDA for safety, effectiveness, or quality before they're marketed — compounding can be appropriate when an FDA-approved option genuinely doesn't meet a patient's need, but it shouldn't be marketed as inherently better just because it's described as customized.[1]
Delivery Route Is a Real Cost Driver
Injectable treatment can involve autoinjectors, vials, syringes, needles, sharps disposal, and injection training — a transparent provider discloses what supplies, instruction, and shipping are actually included in the price.[2]Nasal, sublingual, buccal, topical, and vaginal sexual-wellness products also show up through compounding pharmacies, with cost often reflecting customized formulation, multi-dose containers, and pharmacy handling — but their availability doesn't establish FDA approval or effectiveness for low libido.[1]Worth noting: "topical" needs clarification before you buy anything, since a topical product applied to skin or genital tissue may be meant for local effect, while a transdermal product is designed for systemic absorption — the actual ingredient, route, and intended use determine what a therapy does, not the marketing label.[8]
A specific caution on oxytocin pricing: FDA-approved oxytocin is used in obstetric care — inducing labor and controlling postpartum bleeding — not for libido, HSDD, arousal, orgasm, or bonding. Nasal or sublingual oxytocin marketed for sexual wellness is generally an off-label or compounded approach.[6]The clinical evidence for oxytocin as a libido treatment is limited and inconsistent — small trials of intranasal oxytocin haven't shown a reliable benefit over placebo for sexual function.[7]A higher price on an oxytocin product shouldn't be mistaken for strong evidence behind it.
Labs Aren't Always Necessary — or Included
Broad hormone panels aren't universally required for an HSDD or low-libido evaluation. Testing can be appropriate when a clinician suspects a specific medical contributor, but a transparent provider explains why each test is being ordered, whether it's included in the program price, and whether it's billed to insurance or paid out of pocket.[4]
Look at the Real Ongoing Cost, Not Just the First Month
The first-month price can be misleading. Compare the realistic ongoing cost of the full care path: initial screening, follow-up cadence, the exact medication and route, supplies, pharmacy dispensing, shipping, required renewals, and whether you can change or stop the plan without an ongoing membership commitment. Insurance can change your out-of-pocket cost, but coverage is entirely plan- and medication-specific — ask directly whether the consultation and prescription run through insurance, whether prior authorization or a deductible applies, whether compounded medications are cash-pay only, and whether the quoted price includes all pharmacy and shipping charges.
The Bottom Line
Price shouldn't determine treatment suitability on its own. FDA-approved Vyleesi comes with defined evidence, labeling, and eligibility criteria; compounded bremelanotide and oxytocin-based options carry different regulatory status — and for oxytocin specifically, genuinely limited clinical evidence for libido use. A real clinician should match the treatment to your actual diagnosis and history before cost becomes the deciding factor.[5]
For current pricing across providers, compare options on RENVA's Women's Health / HRT hub rather than relying on figures that go stale as soon as they're published.
Sources
- Compounding and the FDA: Questions and Answers — U.S. Food and Drug Administration fda.gov
- Understanding the Risks of Compounded Drugs — U.S. Food and Drug Administration fda.gov
- International Society for the Study of Women's Sexual Health Process of Care for Management of Hypoactive Sexual Desire Disorder in Women — Mayo Clinic Proceedings mayoclinicproceedings.org
- Treatment of Hypoactive Sexual Desire Disorder Among Women — Focus (via PMC, National Institutes of Health) pmc.ncbi.nlm.nih.gov
- Vyleesi (Bremelanotide) Prescribing Information — U.S. Food and Drug Administration accessdata.fda.gov
- Oxytocin — StatPearls, National Library of Medicine ncbi.nlm.nih.gov
- Effect of Long-Term Intranasal Oxytocin on Sexual Dysfunction in Premenopausal and Postmenopausal Women: A Randomized Trial — Fertility and Sterility (via PubMed) pubmed.ncbi.nlm.nih.gov
- The 2022 Hormone Therapy Position Statement of The North American Menopause Society — The Menopause Society / Menopause menopause.org
Frequently Asked Questions
Is compounded bremelanotide always cheaper than Vyleesi?
Not reliably — the regulatory difference doesn't guarantee a lower price. Compounded pricing depends on formulation, device, and the specific pharmacy, so it's worth confirming directly rather than assuming.[1]
Why do sexual wellness prices vary so much between providers?
Mainly the specific treatment offered (FDA-approved vs. compounded), delivery route, billing structure (membership vs. per-visit), and whether labs and consultations are bundled into the price.
Should I pay more for an oxytocin product marketed as premium?
A higher price doesn't reflect stronger evidence — clinical trials of intranasal oxytocin for libido haven't shown reliable benefit over placebo, regardless of how a product is marketed.[7]
Are labs usually included in sexual wellness program pricing?
It varies by provider, and broad hormone panels aren't universally required for a low-libido evaluation — worth asking whether any included tests are actually necessary for your situation.[4]